Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

oping a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com; Lilly's clinical trial registry is available at www.lillytrials.com.

F-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees with respect to pipeline products that the products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. Pharmaceutical products can develop unexpected safety or efficacy concerns. The company's results may also be affected by such factors as competitive developments affecting current products; market uptake of recently-launched products; the timing of anticipated regulatory approvals and launches of new products; regulatory actions regarding currently marketed products; issues with product supply; regulatory changes or other developments; regulatory compliance problems or government investigations; patent disputes; changes in patent law or regulations related to data-package exclusivity; other litigation involving current or future products; the impact of governmental actions regarding pricing, importation, and reimbursement for pharmaceuticals, including U.S. health care reform; changes in tax law; asset impairments and restructuring charges; acquisitions and business development transactions; and the impact of exchange rates and global
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  AbbVie (NYSE: ... amounts pursuant to its previously announced offer to acquire ... ("Pharmacyclics") for a mix of cash and AbbVie common ... S-4 filed with the Securities and Exchange Commission by ... the assumption that the exchange offer will expire at ...
(Date:5/21/2015)... May 21, 2015 Delcath Systems, Inc. (NASDAQ: ... study cohort of its expanded Global Phase 2 Clinical ... of  patients with unresectable hepatocellular carcinoma (primary liver cancer, ... study will be conducted at the same hospitals in ... Phase 2 HCC trial, and ICC enrollment is now ...
(Date:5/21/2015)... , May 21, 2015 Dipexium ... stage pharmaceutical company focused on the development and ... research collaborators, today announced a scientific poster presentation ... 3 pivotal trials evaluating Locilex®, its novel, broad ... patients with mild infections of diabetic foot ulcers ...
Breaking Medicine Technology:AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 2ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 3ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 2Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 3Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 5
... reached listeners in nine,cities across the United States, ... Adams,Morning Show and nine Radio One gospel radio ... Radiothon on Thursday, April 3,2008, benefiting St. Jude ... United States, the national fundraiser helped raise,awareness for ...
... be Presented at European Association for the Study of the ... Liver Annual ... that it has completed its Phase 2 study of its lead,compound, MitoQ(R) ... The European Association for the Study of the Liver,(EASL) Annual Meeting, being ...
Cached Medicine Technology:The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 2The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 3Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R) 2
(Date:5/22/2015)... 22, 2015 Steven Winter Associates (SWA) ... has been selected by Consulting-Specifying Engineer (CSE) magazine as ... are featured in the May/June issue of the publication. ... professionals age 40 and younger who have, and continue ... well as in other areas of their professional and ...
(Date:5/22/2015)... Portland, Maine (PRWEB) May 22, 2015 ... in single-use swabs for the medical, diagnostic, environmental, ... their entire line of products in the US. ... moving their operations outside the US, Puritan remains ... of products at their Guilford, Maine facility. , ...
(Date:5/22/2015)... Orlando, FL (PRWEB) May 22, 2015 ... United States and developmental projects in rural India. India ... most popular community projects that continues to help hundreds ... is pleased to sponsor a music concert by famous ... fundraise for the Hindu Society of Central Florida ...
(Date:5/21/2015)... The Johns Hopkins Alliance for Science ... Commercial Advisory Board has selected a research project at ... one of two $50,000 Abell Foundation Award for Excellence ... as Anklebot. Developed by the VA Maryland Exercise ... University of Maryland School of Medicine and Massachusetts Institute ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... The Atmananda Yoga Studio and Sequence, is excited ... Atmananda Yoga Mat™, which was previously available for use ... Atmananda Yoga Mat™ unique is that it's mathematically ... prevent serious joint injuries and muscle strains, commonly ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2
... threatened to mobilise US congressmen and senators against Indian authorities ... Act in a case relating to his crusade against the ... wife died of alleged wrongful treatment in India in May ... and congressmen in US and will ask them to raise ...
... scientists has revealed a startling find. Around 75 percent of ... to the risks of developing heart diseases. And thats ... that is connected with diabetes. ,The findings, made by ... people have heart disease even if they do not have clear ...
... warned the consumer against the multiple sites that sell counterfeit ... learned about the 24 related web sites that were involved ... counterfeit versions of Xenical 120 mg capsules was sold from ... help obese people lose weight and maintain it. The capsules ...
... babies with lethal and disabling conditions is illegal worldwide, but ... countries. ,An editorial in this weeks BMJ ... about 200,000 live births occur annually; of these, 10-20 babies ... be actively killed. Yet between 1997 and 2004 only 22 ...
... NIH's National Eye Institute is seeking to raise glaucoma awareness ... disease than others, the Casa Grande Valley Dispatch reports. ... and people with a family history of glaucoma all face ... have primary open-angle glaucoma, the most common form glaucoma. ...
... Sociology, author Alison Howell traces the psychological pathologization of ... resisters of the detainment accredit the attempted suicides to ... ,As the high prevalence of suicide attempts at the ... two major responses have emerged: the United States military ...
Cached Medicine News:Health News:NRI Threatens to Move US Congress for Justice in India 2Health News:Gene Mutations Leave Caucasians Prone To Heart Diseases And Diabetes 2Health News:Should the UK Adopt Dutch Rules on Euthanasia in Newborn Babies? 2Health News:Study Examines the Pathologization of Guantanamo Suicides 2
30 Degree angle....
Leica M500 MS3 robotic stand for neuro, spine surgery and ENT. Motorized XY-movement for precise positioning of the optical axis in eight directions, inclination and tilt....
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Advanced operating microscope with zoom and variable focus up to 500 mm....
Medicine Products: